Article
Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy.
Scientific reports - 13 Jan 2016
Raman Marine C C, Rizkallah Pierre J, Simmons Ruth, Donnellan Zoe, Dukes Joseph, Bossi Giovanna, Le Provost Gabrielle S, Todorov Penio, Baston Emma, Hickman Emma, Mahon Tara, Hassan Namir, Vuidepot Annelise, Sami Malkit, Cole David K, Jakobsen Bent K
Abstract excerpt
Natural T-cell responses generally lack the potency to eradicate cancer. Enhanced affinity T-cell receptors (TCRs) provide an ideal approach to target cancer cells, with emerging clinical data showing significant promise. Nevertheless, the risk of off target reactivity remains a key concern, as exemplified in a recent clinical report describing fatal cardiac toxicity, following administration of MAGE-A3 specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
